share_log

Inspire Veterinary Partners Announces Closing of $6 Million Public Offering

Inspire Veterinary Partners Announces Closing of $6 Million Public Offering

Inspire Veterinary Partners宣佈完成600萬美元的公開發行
Accesswire ·  07/10 12:30

VIRGINIA BEACH, VA / ACCESSWIRE / July 10, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced the closing of its previously announced public offering of 6,000,000 units, each unit consisting of either one share of the Company's Class A common stock or one pre-funded warrant to purchase one share of the Company's Class A common stock and one warrant to purchase one share of the Company's Class A common stock at a public offering price of $1.00 per unit.The pre-funded warrants are issuable to purchasers in lieu of shares of Class A common stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of the Company's outstanding Class A common stock, if any such purchaser so chooses. Each pre-funded warrant is exercisable at any time to purchase one common share at an exercise price of $0.0001 per share. Gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $6.0 million. The Company intends to use the proceeds of the offering for working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).

位於維吉尼亞比奇市的Inspire Veterinary Partners,Inc.(納斯達克:IVP)(以下簡稱“Inspire”或“公司”)是一家在美國提供寵物醫療保健服務的所有者和提供者,今天宣佈關閉其先前宣佈的公開發行600萬個單位的交易,每個單位包括公司A類普通股一股或預先擔保認股權證一份和購買公司A類普通股一股的認股權證一份,公開發行價爲每個單位1.00美元。如果購買者出於任何原因選擇這種方式,預先擔保的認股權證按比例發行給購買者,以代替購買者的受益所有權超過公司現有的A類普通股的4.99%(或在購買者選擇時爲9.99%)的情況。每個預先擔保認股權證可隨時行使,以按每股0.0001美元的行使價格購買一股普通股。除去配售代理的費用和其他發行費用之前,籌集到的總收益約爲600萬美元。公司計劃將這些收益用於營運資金、普通企業目的、向第三方營銷代理支付與營銷和廣告有關的服務、戰略投資以及任何未來的額外收購(如有)。

Spartan Capital Securities LLC is acting as the sole placement agent in connection with the offering.

Spartan Capital Securities LLC是與本次發行相關的唯一配售代理。

The offering was conducted pursuant to the Company's registration statement on Form S-1, as amended (Reg No. 333-280194), initially filed with the Securities and Exchange Commission (the "SEC") on June 14, 2024, and subsequently declared effective by the SEC on July 2, 2024. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained on the SEC's website located at http://www.sec.gov or from Spartan Capital Securities LLC at 725 Fifth Avenue, 23rd Floor, New York, NY 10022, or at

本次發行是根據公司修訂後的S-1表格註冊聲明(註冊編號爲333-280194)進行的,該聲明最初於2024年6月14日向證券交易委員會(以下簡稱“SEC”)提交,並於2024年7月2日由SEC宣佈生效。本次發行僅通過一份招股書進行。有關本次發行的招股書副本可從SEC網址http://www.sec.gov或位於紐約市第五大道725號23樓的Spartan Capital Securities LLC處獲取。

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

此新聞稿不構成任何證券的銷售要約或要約,也不在任何州或其他司法轄區進行出售是違法的,在任何此類州或其他司法轄區之前,該等證券的註冊或符合註冊條件或適用證券法在該等州或其他司法轄區的要求。

About Inspire Veterinary Partners, Inc.

關於Inspire Veterinary Partners,Inc。

Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.

Inspire Veterinary Partners是美國獸醫醫院的所有者/運營商。隨着公司的擴張,它預計將收購其他獸醫醫院,包括一般實踐,混合動物設施和重要和緊急護理。

For more information, please visit: .

欲了解更多信息,請訪問:

Connect with Inspire Veterinary Partners, Inc.

聯繫Inspire Veterinary Partners,Inc。

Facebook

Facebook

LinkedIn

Forward-Looking Statements

LinkedIn

前瞻性聲明

This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's Registration Statements on Form S-1 filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

本新聞稿包含關於公司當前期望的前瞻性聲明。這些聲明並非對未來業績的保證,而且有一定的風險、不確定性和難以預測的因素。可能導致實際結果不同的因素包括但不限於與預期收購相關的慣常結算條件的風險和不確定性,或導致公司預期的收購運營結果發生變化的因素。這些和其他的風險和不確定性在公司向SEC提交的S-1表格註冊聲明的“風險因素”一節中有更詳細的描述。本公告中包含的前瞻性聲明爲本日期作出,並且除非適用法律要求,在此之後公司不承擔更新此類信息的責任。

Investor Contact

投資者聯繫方式

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

General Inquiries

一般查詢

Morgan Wood
Mwood@inspirevet.com

摩根伍德
Mwood@inspirevet.com

SOURCE: Inspire Veterinary Partners, Inc.

來源:Inspire Veterinary Partners, Inc.


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論